Italy – OPEN PROCEDURE FOR THE AWARDING OF A CONTRACT RESEARCH ORGANIZATION (CRO) OF SERVICES FOR THE MANAGEMENT OF THE MULTI-CENTER RANDOMIZED CLINICAL TRIAL: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI INMETASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, VIA SINTEL PLATFORM

This tender document contains detailed specifications, requirements, and submission guidelines. Purchase access to view the full document including eligibility criteria, scope of work, and evaluation methodology.

The complete document includes all annexes, terms of reference, and bidding instructions required for your submission.

Contact the procuring entity directly for pre-bid inquiries and clarifications.